Results of a recent study suggest that high-risk multiple myeloma patients who have chromosomal abnormalities known as trisomies have better survival outcomes than high-risk patients without them.

“Our findings allow us to further trim down the proportion of patients with truly high-risk disease, thus allowing us to concentrate on those patients and improve their outcome,” said Dr. Shaji Kumar of the Mayo Clinic in Rochester, Minnesota, and lead author of the study.

Based on their results, the researchers recommended a new and more specific method of classifying myeloma patients based on their …